Abbott Wins FDA Approval for Much-Anticipated Diabetes App
- Users previously had to use separate devices to read levels
- Competitors Medtronic, DexCom already had smartphone services
This article is for subscribers only.
Abbott Laboratories won U.S. approval for its FreeStyle LibreLink diabetes-monitoring app, giving users a way to keep track of their glucose levels from their iPhones.
The app works with Abbott’s FreeStyle Libre glucose sensors, which have rapidly become some of the top-selling medical devices in the U.S. It is likely to be a welcome addition for millions of customers who currently rely on separate pocket-sized gadgets to read their results. Rivals Medtronic Plc and DexCom Inc. already had smartphone capability for their glucose systems.